Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin‐diabetic rats

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Archiv der Pharmazie

• Publication date

  2001-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/1521-4184(200112)334:12<388::AID-ARDP388>3.0.CO;2-9PMID 11852534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spectroscopic properties of a novel neutral proteinase from Saccharomonospora canescens.

  2000cited by this paper
• Influence of sodium bis(oxalato)oxovanadate(IV) on phospholipids in liver Golgi fractions from control and streptozotocin-diabetic rats.

  2000cited by this paper
• Biochemical and Morphological Alterations in Rat Liver Golgi Complexes After Treatment with Bis(maltolato)oxovanadium(IV) [BMOV] orMaltol Alone

  2000cited by this paper
• Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone.

  2000cited by this paper
• Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate.

  1999cited by this paper
• Possible mechanism of action of vanadium ions as an antidiabetic agent.

  1999cited by this paper
• Vanadium compounds as insulin mimics.

  1999cited by this paper
• Vanadium compounds as insulin mimics.

  1999cited by this paper
• [Insulin-like effect of vanadium compounds].

  1998cited by this paper
• Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation.

  1998cited by this paper
• Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound.

  1997cited by this paper
• Potentiometric, Calorimetric, and Solution NMR Studies of a Tridentate Ligand Which has a Marked Preference for Formation of Bis(ligand) versus Mono(ligand) Lanthanide Complexes and Which Exhibits High Selectivity for Heavier Lanthanides

  1995cited by this paper
• Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases

  1995cited by this paper
• Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat

  1995cited by this paper
• Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.

  1995cited by this paper
• Vanadium in mammalian physiology and nutrition.

  1995cited by this paper
• Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent

  1995cited by this paper
• One-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or haematological indices.

  1994cited by this paper
• Interaction of vanadium and phosphorus in chicks

  1994cited by this paper
• In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.

  1993cited by this paper
• Place du vanadium dans le traitement du diabète : données expérimentales et applications cliniques

  1992cited by this paper
• Gene expression of regulatory enzymes of glycolysis/gluconeogenesis in regenerating rat liver.

  1992cited by this paper
• [Role of vanadium in the treatment of diabetes mellitus. Experimental data and clinical applications].

  1992cited by this paper
• Peroxovanadates have full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle.

  1991cited by this paper
• Lipoprotein lipase in experimental diabetic rats: beneficial effect of vanadate treatment.

  1991cited by this paper
• The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?

  1991cited by this paper
• Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats.

  1985cited by this paper
• Complexes of oxovanadium(IV)

  1962cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• The Influence of Organic Vanadium Complexes on an Antioxidant Profile in Adipose Tissue in Wistar Rats

  2022cites this paper
• Investigation of the influence of vanadium compounds treatment in NZO mice model--preliminary study.

  2014cites this paper
• Assemblies of salen-type oxidovanadium(IV) complexes: substituent effects and in vitro protein tyrosine phosphatase inhibition.

  2014cites this paper
• Novel vanadyl complexes of acetoacetanilide: Synthesis, characterization and inhibition of proteintyrosine phosphatase

  2013cites this paper
• Influence of Vanadium–organic Ligands Treatment on Selected Metal Levels in Kidneys of STZ Rats

  2013cites this paper
• Quantum mechanical study of the tautomerism and molecular spectra of 2-hydroxy-3-methyl-2-cyclopenten-1-one

  2012cites this paper
• Effect of alkali metal ion and hydrogen bonds on thermal stability of M[VO(O2)2bpy]·nH2O (M = Li+–Rb+) and Cs[VO(O2)2bpy]·H2O2 complexes

  2011cites this paper
• Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B

  2010cites this paper
• Vanadium complex of 2-(2'-Pyridyl)-4,5-dicyanoimidazole showing spermicidal and cytotoxic properties.

  2006cites this paper
• Vibrational and computational study on maltol (3-hydroxy-2-methyl-4h-pyran-4-one) polymorphism

  2005cites this paper